VISIE
Austin
About VISIE
Advanced Scanners provide optimal 3D surface mapping for precise intra-operative diagnostics and positioning. Ummet Clinical's need revolves around addressing a critical issue highlighted in a 2017 FDA safety notification. The notification emphasized the alarming consequences resulting from surgical navigation systems' inability to accurately track intra-operative shifts in patient anatomy, leading to severe outcomes such as patient deaths, life-threatening injuries, and disrupted medical procedures. Despite some advancements, a significant gap persists in obtaining real-time, precise imaging data for location-correct procedures. In response, Advanced Scanners has developed a groundbreaking solution’a patented optical scanning platform that revolutionizes real-time surface mapping of patient anatomy. This innovative device eliminates the need for contact or harmful radiation while providing unparalleled accuracy. Advanced Scanners stands out as one of the few pioneering companies actively addressing this crucial issue. Their ongoing efforts span a wide range of applications, aiming to empower the next generation of image-guided navigation, robotic assistance, and AI-enhanced interventions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $20.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2023)
- Website: visievision.com
- Phone: 512-750-6570
Industries & Categories
Health Care, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/visie-81115 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.